Literature DB >> 34465163

Imbalance in Heart Transplant to Heart Failure Mortality Ratio by Sex.

Khadijah Breathett1, Shannon M Knapp2, Molly Carnes3, Elizabeth Calhoun4, Nancy K Sweitzer1.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 34465163      PMCID: PMC8649229          DOI: 10.1161/JAHA.120.020146

Source DB:  PubMed          Journal:  J Am Heart Assoc        ISSN: 2047-9980            Impact factor:   6.106


× No keyword cloud information.
Allocation of heart transplants may be inequitable by sex. For over a decade, women have received <25% of heart transplants. Women have similar prevalence of heart failure (HF) as men, but higher HF mortality. Women also have higher prevalence of HF with preserved ejection fraction, which has limited benefit with heart transplant, than men. However, among the highest risk population that has recurrent heart failure hospitalizations, women have similar prevalence of HF with preserved ejection fraction and HF with reduced ejection fraction (HFrEF). Adding the intersection of race results in higher prevalence of HFrEF among subgroups such as Black women. In comparison, the majority of men with recurrent HF hospitalizations have HFrEF. Since HFrEF can be treated with heart transplants, this suggests a heart transplant sex disparity. Geographic and center culture may contribute to disparities in heart transplant allocation. Given observed sex bias in the allocation of heart transplants, we sought to determine whether heart transplant rate to HF mortality rate varied geographically across the United States for women compared with men. It is important to identify geographic areas with the greatest disparities so that interventions can be appropriately tailored to achieve equity. Using data from the United Network for Organ Sharing and Centers for Disease Control and Prevention Wide‐Ranging Online Data for Epidemiological Research we examined heart transplant and HF mortality (underlying cause of death International Classification of Diseases, Tenth Revision (ICD‐10: I50 [I50.0, I50.1, I50.9]) ratio by sex from 2016 to 2018 nationally and by state among adults aged 35 to 64 years since this age group receives the majority of heart transplants. All 50 states plus D.C. were included for the national analysis. Among state analyses, states were excluded for missing HF mortality (9 states+D.C.), which was either suppressed or marked unreliable by Centers for Disease Control and Prevention Wide‐Ranging Online Data for Epidemiological Research for <20 HF deaths or risk of identifying individuals. The national cohort included 19 784 HF deaths and 5800 heart transplants; the final state cohort included 19 497 HF deaths and 5641 heart transplants (n=41 states). The University of Arizona Institutional Review Board exempted this study from review. Data are publicly available from United Network for Organ Sharing and Centers for Disease Control and Prevention Wide‐Ranging Online Data for Epidemiological Research. The primary outcome was heart transplant rate to HF mortality rate ratio. Ratios were calculated for each sex nationally and by state as the number of transplants per 100 000 population per year divided by the age‐adjusted HF mortality rate per 100 000 population per year. Heart transplant to HF mortality ratios were compared between women and men, with the ratio for men as the control. Calculations were completed using R version 3.6.3 (Vienna, Austria). In national analyses, women received 0.789 heart transplants per 100 000 per year, and men received 2.330 heart transplants per 100 000 per year. The heart transplant to HF mortality ratio was 0.263 for women and 0.424 for men, resulting in lower ratio for women versus men at 0.620. In the state analyses, 98% (40 of 41 states) had lower ratios for women compared with men (Table). Ratios were higher for women compared with men only in Connecticut. The lowest median heart transplant to HF mortality ratio was observed in the Southern region at 0.537 (interquartile range, 0.424–0.695) followed by Northeast at 0.545 (interquartile range, 0.519–0.716), West at 0.604 (interquartile range, 0.517–0.719), and Midwest at 0.646 (interquartile range, 0.569–0.707).
Table 1

Ratio of Heart Transplantation to Heart Failure Mortality by Sex 2016 to 2018

StateRegionTransplant Rate WomenHF Mortality Rate WomenTransplant Rate MenHF Mortality Rate MenTransplant to Mortality Ratio WomenTransplant to Mortality Ratio MenRatio Women to Men
All0.7893.002.3305.500.2630.4240.620
West VirginiaSouth0.3674.082.5185.390.0900.4670.193
New JerseyNortheast0.4132.132.4103.650.1940.6600.294
TennesseeSouth0.9474.344.0087.110.2180.5640.387
AlabamaSouth0.3087.911.50815.970.0390.0940.413
DelawareSouth0.8662.702.6463.460.3210.7650.419
KentuckySouth0.8326.412.8959.490.1300.3050.426
IdahoWest0.3201.981.2863.670.1620.3500.461
WisconsinMidwest0.6181.542.2322.570.4010.8690.462
ArkansasSouth0.5834.932.3039.500.1180.2420.488
New MexicoWest0.2562.160.9774.060.1180.2410.492
NevadaWest0.4612.111.6603.810.2190.4360.502
GeorgiaSouth0.4456.421.60911.660.0690.1380.502
New YorkNortheast0.7421.322.7092.500.5621.0840.519
MississippiSouth0.80011.132.53318.290.0720.1380.519
OhioMidwest0.7843.532.3315.490.2220.4250.523
MinnesotaMidwest0.6221.232.1622.330.5050.9280.545
MassachusettsNortheast0.9822.062.6673.050.4770.8740.545
FloridaSouth0.8042.102.5003.630.3830.6890.556
UtahWest0.7112.472.0484.020.2880.5090.565
OklahomaSouth0.5033.941.4476.430.1280.2250.567
HawaiiWest0.3721.891.4944.360.1970.3430.575
North CarolinaSouth0.9844.252.7627.030.2320.3930.589
CaliforniaWest0.6262.032.1104.330.3090.4870.633
OregonWest0.5753.041.3394.510.1890.2970.638
MissouriMidwest0.7304.491.8937.460.1630.2540.641
IllinoisMidwest0.9633.402.8516.500.2830.4390.645
MichiganMidwest0.6423.261.7315.680.1970.3050.647
IowaMidwest0.9141.931.9862.880.4730.6900.686
South CarolinaSouth0.6325.521.66510.040.1150.1660.691
VirginiaSouth0.9993.952.7977.820.2530.3580.707
KansasMidwest1.3032.513.3144.560.5190.7270.714
PennsylvaniaNortheast0.9072.512.4434.840.3610.5050.716
NebraskaMidwest1.4312.503.4034.380.5720.7770.737
TexasSouth0.9083.432.3906.650.2650.3590.737
WashingtonWest1.1141.162.7682.150.9611.2870.746
MarylandSouth1.1701.662.8183.030.7050.9300.758
IndianaMidwest1.2203.822.6546.640.3190.4000.799
LouisianaSouth0.7378.871.55615.450.0830.1010.825
ColoradoWest0.6451.361.4602.730.4740.5350.887
ArizonaWest0.7960.812.2242.070.9821.0740.914
ConnecticutNortheast1.3931.203.0463.251.1610.9371.238

Rates are per 100 000 per year among patients aged 35 to 64 years. HF indicates heart failure.

Multiple factors contribute to low allocation of heart transplant to women. This study was not able to adjust for clinical factors, patients' preferences, social determinants of health, or sex bias. Rather a general overview of transplant disparities is provided at a geographic level. Given known sex inequities in pharmacological and non‐pharmacological management of heart failure, this study provides fuel to explore cultural decision‐making contributing to low transplant rates among women. As crude analyses, we were unable to stratify results by phenotype contributing to HF mortality and are at risk for unmeasured confounding variables as with any observational study. However, among the highest risk group with recurrent HF hospitalizations, HF with preserved ejection fraction was a greater cause of annual mortality than HFrEF among White men in 1 national study. Conversely HFrEF was a greater cause of annual mortality than HF with preserved ejection fraction among women. This suggests that sex disparities in transplant to mortality ratio may be underestimated. In addition, taking ratios of ratios may amplify small differences. For this reason, we included a table of individual rates and ratios by sex to surmise sex differences among and across states. Among the United States, women had lower heart transplant to HF mortality rate ratios than men. Disparities were widespread but were the worst in the US South. Implementation of strategies to achieve sex equity in allocation of heart transplants should be investigated across the United States.

Sources of Funding

None.

Disclosures

Dr Breathett has research funding from Women As One Escalator Award; National Heart, Lung, and Blood Institute K01HL142848, R25HL126146 subaward 11692sc, and L30HL148881; University of Arizona Health Sciences, Strategic Priorities Faculty Initiative Grant; University of Arizona, Sarver Heart Center, Novel Research Project Award in the Area of Cardiovascular Disease and Medicine, Anthony and Mary Zoia Research Award; and American Heart Association Get With The Guidelines Young Investigator Database Seed Grant Award. Dr Carnes's research on scientific workforce diversity is funded by National Institute of General Medical Sciences R35GM122557. The remaining authors have no disclosures to report. Ratio of Heart Transplantation to Heart Failure Mortality by Sex 2016 to 2018 Rates are per 100 000 per year among patients aged 35 to 64 years. HF indicates heart failure.
  6 in total

1.  Trends in Hospitalizations and Survival of Acute Decompensated Heart Failure in Four US Communities (2005-2014): ARIC Study Community Surveillance.

Authors:  Patricia P Chang; Lisa M Wruck; Eyal Shahar; Joseph S Rossi; Laura R Loehr; Stuart D Russell; Sunil K Agarwal; Suma H Konety; Carlos J Rodriguez; Wayne D Rosamond
Journal:  Circulation       Date:  2018-03-08       Impact factor: 29.690

2.  OPTN/SRTR 2018 Annual Data Report: Heart.

Authors:  M Colvin; J M Smith; N Hadley; M A Skeans; K Uccellini; R Goff; J Foutz; A K Israni; J J Snyder; B L Kasiske
Journal:  Am J Transplant       Date:  2020-01       Impact factor: 8.086

Review 3.  Sex Differences in Advanced Heart Failure Therapies.

Authors:  Eileen M Hsich
Journal:  Circulation       Date:  2019-02-19       Impact factor: 29.690

4.  Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association.

Authors:  Salim S Virani; Alvaro Alonso; Emelia J Benjamin; Marcio S Bittencourt; Clifton W Callaway; April P Carson; Alanna M Chamberlain; Alexander R Chang; Susan Cheng; Francesca N Delling; Luc Djousse; Mitchell S V Elkind; Jane F Ferguson; Myriam Fornage; Sadiya S Khan; Brett M Kissela; Kristen L Knutson; Tak W Kwan; Daniel T Lackland; Tené T Lewis; Judith H Lichtman; Chris T Longenecker; Matthew Shane Loop; Pamela L Lutsey; Seth S Martin; Kunihiro Matsushita; Andrew E Moran; Michael E Mussolino; Amanda Marma Perak; Wayne D Rosamond; Gregory A Roth; Uchechukwu K A Sampson; Gary M Satou; Emily B Schroeder; Svati H Shah; Christina M Shay; Nicole L Spartano; Andrew Stokes; David L Tirschwell; Lisa B VanWagner; Connie W Tsao
Journal:  Circulation       Date:  2020-01-29       Impact factor: 29.690

5.  Imbalance in Heart Transplant to Heart Failure Mortality Ratio by Sex.

Authors:  Khadijah Breathett; Shannon M Knapp; Molly Carnes; Elizabeth Calhoun; Nancy K Sweitzer
Journal:  J Am Heart Assoc       Date:  2021-09-01       Impact factor: 6.106

6.  Association of Gender and Race With Allocation of Advanced Heart Failure Therapies.

Authors:  Khadijah Breathett; Erika Yee; Natalie Pool; Megan Hebdon; Janice D Crist; Ryan H Yee; Shannon M Knapp; Sade Solola; Luis Luy; Kathryn Herrera-Theut; Leanne Zabala; Jeff Stone; Marylyn M McEwen; Elizabeth Calhoun; Nancy K Sweitzer
Journal:  JAMA Netw Open       Date:  2020-07-01
  6 in total
  3 in total

1.  Imbalance in Heart Transplant to Heart Failure Mortality Ratio by Sex.

Authors:  Khadijah Breathett; Shannon M Knapp; Molly Carnes; Elizabeth Calhoun; Nancy K Sweitzer
Journal:  J Am Heart Assoc       Date:  2021-09-01       Impact factor: 6.106

2.  Sex Equity in Heart Transplant Allocation: What Is Good for the Goose Is Good for the Gander.

Authors:  Selma Mohammed
Journal:  J Am Heart Assoc       Date:  2021-09-01       Impact factor: 6.106

Review 3.  Special Considerations in the Care of Women With Advanced Heart Failure.

Authors:  Imo A Ebong; Ersilia M DeFilippis; Eman A Hamad; Eileen M Hsich; Varinder K Randhawa; Filio Billia; Mahwash Kassi; Anju Bhardwaj; Mirnela Byku; Mrudala R Munagala; Roopa A Rao; Amy E Hackmann; Claudia G Gidea; Teresa DeMarco; Shelley A Hall
Journal:  Front Cardiovasc Med       Date:  2022-07-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.